<img alt="" height="1" width="1" />IPO sector hit by market volatilityFinancial TimesIronwood Pharmaceuticals of the US, which is developing a treatment for chronic constipation and irritable bowel syndrome, priced its IPO at $11.25 per ...<nobr>and more »</nobr> |